232 related articles for article (PubMed ID: 12149148)
1. An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.
Yoshida S; Kawaguchi H; Sato S; Ueda R; Furukawa K
Jpn J Cancer Res; 2002 Jul; 93(7):816-24. PubMed ID: 12149148
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis.
Aixinjueluo W; Furukawa K; Zhang Q; Hamamura K; Tokuda N; Yoshida S; Ueda R; Furukawa K
J Biol Chem; 2005 Aug; 280(33):29828-36. PubMed ID: 15923178
[TBL] [Abstract][Full Text] [Related]
3. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells.
Zhu W; Mao X; Wang W; Chen Y; Li D; Li H; Dou P
Pharmazie; 2018 Feb; 73(2):80-86. PubMed ID: 29442009
[TBL] [Abstract][Full Text] [Related]
4. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Shafer SH; Williams CL
Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway.
Ohtsuka T; Buchsbaum D; Oliver P; Makhija S; Kimberly R; Zhou T
Oncogene; 2003 Apr; 22(13):2034-44. PubMed ID: 12673208
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
[TBL] [Abstract][Full Text] [Related]
7. Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells.
Levresse V; Marek L; Blumberg D; Heasley LE
Mol Pharmacol; 2002 Sep; 62(3):689-97. PubMed ID: 12181446
[TBL] [Abstract][Full Text] [Related]
8. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
MacKinnon AC; Armstrong RA; Waters CM; Cummings J; Smyth JF; Haslett C; Sethi T
Br J Cancer; 1999 Jun; 80(7):1026-34. PubMed ID: 10362111
[TBL] [Abstract][Full Text] [Related]
9. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
10. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines.
Vasilevskaya IA; Rakitina TV; O'Dwyer PJ
Mol Pharmacol; 2004 Jan; 65(1):235-43. PubMed ID: 14722256
[TBL] [Abstract][Full Text] [Related]
11. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress.
Benhar M; Dalyot I; Engelberg D; Levitzki A
Mol Cell Biol; 2001 Oct; 21(20):6913-26. PubMed ID: 11564875
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.
Yoshida S; Fukumoto S; Kawaguchi H; Sato S; Ueda R; Furukawa K
Cancer Res; 2001 May; 61(10):4244-52. PubMed ID: 11358851
[TBL] [Abstract][Full Text] [Related]
13. Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line.
Viktorsson K; Ekedahl J; Lindebro MC; Lewensohn R; Zhivotovsky B; Linder S; Shoshan MC
Exp Cell Res; 2003 Oct; 289(2):256-64. PubMed ID: 14499626
[TBL] [Abstract][Full Text] [Related]
14. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
Krystal GW; Honsawek S; Litz J; Buchdunger E
Clin Cancer Res; 2000 Aug; 6(8):3319-26. PubMed ID: 10955819
[TBL] [Abstract][Full Text] [Related]
15. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation.
Butterfield L; Storey B; Maas L; Heasley LE
J Biol Chem; 1997 Apr; 272(15):10110-6. PubMed ID: 9092556
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells.
Lin CC; Shen YC; Chuang CK; Liao SK
Adv Exp Med Biol; 2001; 491():419-29. PubMed ID: 14533812
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression.
Hershberger PA; McGuire TF; Yu WD; Zuhowski EG; Schellens JH; Egorin MJ; Trump DL; Johnson CS
Mol Cancer Ther; 2002 Aug; 1(10):821-9. PubMed ID: 12492115
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
19. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway.
Bae MA; Pie JE; Song BJ
Mol Pharmacol; 2001 Oct; 60(4):847-56. PubMed ID: 11562448
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-tumor effect of trastuzumab in combination with cisplatin.
Naruse I; Fukumoto H; Saijo N; Nishio K
Jpn J Cancer Res; 2002 May; 93(5):574-81. PubMed ID: 12036454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
